- $40.15m
- $51.67m
- $375.69m
- 19
- 84
- 48
- 49
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 282 | 307 | 301 | 350 | 376 |
Cost of Revenue | |||||
Gross Profit | 91.3 | 100 | 96.9 | 120 | 118 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 275 | 314 | 315 | 382 | 408 |
Operating Profit | 7.18 | -7.03 | -13.9 | -32.3 | -32.2 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4.56 | -9.68 | -19.6 | -31.5 | -35.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.84 | -13.3 | -23.1 | -34.7 | -37.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 2.77 | -13.5 | -23.1 | -34.7 | -37.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.77 | -13.5 | -23.1 | -34.7 | -37.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.217 | -0.484 | -0.833 | -0.565 | -1.17 |